Reshape Lifesciences Inc (RSLS)
0.3904 -0.0596 (-13.24%) 13:59 ET [NASDAQ]
0.3925 x 900 0.3950 x 100
Realtime by (Cboe BZX)
0.3925 x 900 0.3950 x 100
Realtime 0.3831 -0.0669 (-) 09:29 ET
for Thu, Apr 3rd, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,387 | -46,214 | -63,146 | -21,630 | -74,207 |
| Depreciation Amortization | 154 | 2,153 | 2,465 | 3,364 | 8,294 |
| Income taxes - deferred | 28 | -423 | -248 | -86 | -1,143 |
| Accounts receivable | 125 | 678 | -284 | 1,217 | -3,619 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | -992 | 1,629 |
| Other Working Capital | -4,134 | 709 | -2,712 | -46 | -1,406 |
| Other Operating Activity | -1,746 | 21,195 | 48,550 | 9,623 | 56,252 |
| Operating Cash Flow | $-16,960 | $-21,902 | $-15,375 | $-8,550 | $-14,200 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10 | -92 | -352 | -2,390 | -2,014 |
| Net Acquisitions | N/A | N/A | 2,207 | N/A | N/A |
| Investing Cash Flow | $-10 | $-92 | $1,855 | $-2,390 | $-2,014 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 9,500 | N/A |
| Debt Issued | N/A | N/A | 1,000 | 955 | 2,000 |
| Debt Repayment | N/A | N/A | -10,500 | N/A | -2,200 |
| Common Stock Issued | 17,574 | 3,130 | 46,033 | 679 | 13,924 |
| Other Financing Activity | 0 | 0 | -3,234 | -59 | -65 |
| Financing Cash Flow | $17,574 | $3,130 | $33,299 | $11,075 | $13,659 |
| Exchange Rate Effect | N/A | 4 | 29 | -113 | -8 |
| Beginning Cash Position | 3,955 | 22,815 | 3,007 | 2,985 | 5,548 |
| End Cash Position | 4,559 | 3,955 | 22,815 | 3,007 | 2,985 |
| Net Cash Flow | $604 | $-18,860 | $19,808 | $22 | $-2,563 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,960 | -21,902 | -15,375 | -8,550 | -14,200 |
| Capital Expenditure | -43 | -131 | -352 | -2,390 | -2,014 |
| Free Cash Flow | -17,003 | -22,033 | -15,727 | -10,940 | -16,214 |